We are dedicated to advancing medicine & redefining patient care, one clinical trial at a time — with compassion. We are a network of clinical trial sites based in Michigan, & Texas.
Blogs written by @revadmin1
December 5, 2023
Westland, Michigan on 8th & 9th December — Revival Research Institute is pleased to announce its highly anticipated All Hands Meeting Session III, 2023, scheduled to take place on 8th & 9th December at Westland, Michigan.
October 6, 2023
Florida, October 6th, 2023 – Revival Research Institute, a leading innovator in the Clinical Research industry is thrilled to announce its participation at the upcoming SCRS Global Summit 2023. This event is set to take place from 6th-8th October in Hollywood, Florida.
July 11, 2023
Michigan, July 21, 2023 — Revival Research Institute is proud to collaborate with Eli Lilly to conduct health screenings at this year’s Ann Arbor Art Fair. This screening event is a part of Revival’s ongoing efforts for a potentially healthier community through its clinical trials.
May 24, 2023
Philadelphia, 24th May 2023 — Revival Research Institute is pleased to announce its representation at the WCG MAGI Clinical Research Conference - 2023 in Philadelphia.
May 11, 2023
Michigan, May 11, 2023 — Revival Research Institute is coming to the 42nd Annual Art Birmingham on May 13 & 14, 2023, produced by the Birmingham Bloomfield Art Center in association with The Guild of Artists & Artisans, Birmingham, MI.
January 26, 2023
Michigan, January 26, 2023 — Embarking into 2023 with a brand new look, but the same old vision.
December 28, 2022
Michigan, December 28, 2022 — with the year 2022 coming to an end, I would like to extend my gratitude to each one of my team members without whom we would not have been able to achieve the milestones set for this year.
June 21, 2022
Michigan, June 21, 2022 — Revival Research Institute is excited and proud to be collaborating with Eli Lilly to conduct a Alzheimer’s and Brain Health Screening Event at the Ann Arbor Art Fair 2022. This screening event is a part of the Preventive Alzheimer’s Research Study, TRAILBLAZER-ALZ 3.